Skip to main content

Table 7 Cox regression analysis on GC-related hospitalization, 3-level definition of corticosteroid treatment, including CCI (non-rheumatologic comorbidities vs rheumatologic comorbidities only)

From: Influence of initial glucocorticoid co-medication on mortality and hospitalization in early inflammatory arthritis: an investigation by record linkage of clinical and administrative databases

 

HR (95% CI)

Adj HR (95% IC)

No GC

Ref

Ref

GC ≤ 7.5 mg/day

1.06 (0.71, 1.59)

1.30 (0.84, 1.99)

GC > 7.5 mg/day

0.73 (0.42, 1.27)

0.71 (0.38, 1.31)

Female gender

-

0.41 (0.28, 0.61)

Age

-

1.07 (1.05, 1.09)

HAQ

-

1.31 (1, 1.72)

CCI >1

-

1.80 (1.17, 2.78)

MTX

-

1.15 (0.68, 1.95)

ACPA

-

1.81 (1.07, 3.05)

  1. GC glucocorticoid, HR hazard ratio, CI confidence interval, HAQ Health Assessment Questionnaire, CCI Charlson Comorbidity Index, MTX methotrexate, ACPA anti-cyclic citrullinated peptide antibodies
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us